Home > Insider Trading > Filing (0001562180-22-002559)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1636422	Health Catalyst Inc.	HCAT	Services-Computer Programming, Data Processing, Etc. (7370)	453337483

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780978	Paul Horstmeier	C/O Health Catalyst, Inc. 10897 South River Front Parkway, #300 South Jordan UT 84095	Chief Operating Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-03-09	521	$15.84	196,877	No	4	M	Direct
Common Stock	Acquisiton	2022-03-09	4,166	$15.84	201,043	No	4	M	Direct
Common Stock	Disposition	2022-03-09	23,008	$25.30	178,035	No	4	S	Direct
Common Stock	Disposition	2022-03-09	201	$26.02	177,834	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-03-09	4,166	$0.00	4,166	$15.84
Common Stock	Stock Option (Right to Buy)	Disposition	2022-03-09	521	$0.00	521	$15.84

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,569		2029-02-05	No	4	M	Direct
6,248		2029-02-05	No	4	M	Direct

Footnotes

The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.00 to $25.96, inclusive.
Represents the weighted average sale price of the shares sold ranging from $26.00 to $26.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
25% of the 25,000 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.